ProGenis Pharmaceuticals

Bentley, Australia

ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.

$65K raised

Nov 2025

Grant

Manufacturing Pharmaceutical Therapeutics

Top Investors

MTPConnect Future Health Research and Innovation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ProGenis Pharmaceuticals

How much funding has ProGenis Pharmaceuticals raised?

ProGenis Pharmaceuticals has raised $65K in total funding. The most recent round was Grant. The last funding was announced in November 2025.

Who are ProGenis Pharmaceuticals's investors?

ProGenis Pharmaceuticals's investors include MTPConnect, Future Health Research and Innovation.

Where is ProGenis Pharmaceuticals headquartered?

ProGenis Pharmaceuticals is headquartered in Bentley, Australia.

What does ProGenis Pharmaceuticals do?

ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.

What stage is ProGenis Pharmaceuticals at?

ProGenis Pharmaceuticals is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 19, 2025.

MLA

"ProGenis Pharmaceuticals — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/progenis-pharmaceuticals. Accessed July 5, 2026.

APA

VCBacked. (2025). ProGenis Pharmaceuticals — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/progenis-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=ProGenis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/progenis-pharmaceuticals |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 19, 2025.